Catalyst Biosciences - M&A Summary and Business Overview

Life ScienceCompany

Catalyst Biosciences M&A Summary

Catalyst Biosciences has acquired 1 company. It has also divested 2 assets.

It’s largest disclosed sale occurred in 2022, when it sold Catalyst Biosciences - Protease Medicines to for $60M. Catalyst Biosciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Catalyst Biosciences Business Overview

Where is Catalyst Biosciences headquartered?

Catalyst Biosciences is headquartered in San Francisco, California.

What sector is Catalyst Biosciences in?

Catalyst Biosciences is a life science company.

When was Catalyst Biosciences founded?

Catalyst Biosciences was founded in 2002.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity1
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 4

Catalyst Biosciences, Inc.

260 Littlefield Avenue South,
San Francisco, California 94080
United States,
(650) 871-0761
www.catalystbiosciences.com

Catalyst Biosciences, Inc. is a privately held biotechnology company focused on engineering and developing novel therapeutic protease products.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.4/yr) # - - - 1 1 - 2
vol $60M $60M
  3

Most Recent M&A

Company Date Value Type
Catalyst Biosciences - Rare Disease Pipeline in Hematology 2023-02-28 - Divestiture
San Francisco, California
Catalyst Biosciences - Protease Medicines 2022-05-24 60M USD Divestiture
San Francisco, California
Targacept, Inc. 2015-03-05 - Merger
Winston-Salem, North Carolina · www.targacept.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - 2 (100%) 60M (100%)
Total 1 - 2 $60M

By Geo

State/Country Buy Value Sell Value
United States 1 - 2 60M
  California - - 2 60M
  North Carolina 1 - - -
Total 1 - 2 $60M

Top M&A Advisors

Financial Deals
Perella Weinberg Partners
1
Legal Deals
Potter Anderson & Corroon
1
Morrison & Foerster
1
Orrick
1

Deal Values

sell # Total
< $100M 1 $60M
TOTAL $60M
Largest Catalyst Biosciences - Protease Medicines
$60M (2022-05-24)

M&A Connections

Deals
Divested to
Strategic(s)
50%
1 (50%)

 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.